Targeting the gut-liver axis in liver disease

被引：325

作者：

Wiest, Reiner ^{[1
]}

Albillos, Agustin ^{[2
]}

Trauner, Michael ^{[3
]}

Bajaj, Jasmohan S. ^{[4
,5
]}

Jalan, Rajiv ^{[6
]}

机构：

[1] Univ Hosp, Gastroenterol, CH-3010 Bern, Switzerland

[2] Hosp Univ Ramon & Cajal, Gastroenterol & Hepatol, Madrid, Spain

[3] Med Univ Vienna, Div Gastroenterol & Hepatol, Dept Internal Med 3, Vienna, Austria

[4] Virginia Commonwealth Univ, Richmond, VA USA

[5] McGuire VA Med Ctr, GI Hepatol, Richmond, VA USA

[6] UCL, Inst Hepatol, London, England

来源：

JOURNAL OF HEPATOLOGY | 2017年 / 67卷 / 05期

基金：

欧盟地平线“2020”;

关键词：

Gut-liver-axis; Bacterial translocation; Liver injury; Fibrosis; Cirrhosis; Bile acids; Microbiome; Incretines; Pre-; probiotics; Faecal microbial transplantation; PRIMARY SCLEROSING CHOLANGITIS; NONSELECTIVE BETA-BLOCKERS; RANDOMIZED CONTROLLED-TRIAL; SECRETORY IMMUNOGLOBULIN-A; CONTROLLED CLINICAL-TRIAL; BACTERIAL TRANSLOCATION; HEPATOCELLULAR-CARCINOMA; OBETICHOLIC ACID; HEPATIC-ENCEPHALOPATHY; DOUBLE-BLIND;

D O I：

10.1016/j.jhep.2017.05.007

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

The gut-liver axis is widely implicated in the pathogenesis of liver diseases, where it is increasingly the focus of clinical research. Recent studies trialling an array of therapeutic and preventative strategies have yielded promising results. Considering these strategies, the armamentarium for targeting the gut-liver axis will continue to expand. Further clinical trials, translated from our current knowledge of the gut-liver axis, promise an exciting future in liver treatment. (C) 2017 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

引用

页码：1084 / 1103

页数：20

共 166 条

[1]

van Baar ACG, 2016, HEPATOLOGY, V64, pA557

[2] Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhosis: An Open-Label, Randomized Controlled Trial of Lactulose, Probiotics, and No Therapy [J].

Agrawal, Amit ;

Sharma, Barjesh Chander ;

Sharma, Praveen ;

Sarin, Shiv Kumar .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (07) :1043-1050

[3] Enhancement of functional connectivity, working memory and inhibitory control on multi-modal brain MR imaging with Rifaximin in Cirrhosis: Implications for the gut-liver-brain axis [J].

Ahluwalia, Vishwadeep ;

Wade, James B. ;

Heuman, Douglas M. ;

Hammeke, Thomas A. ;

Sanyal, Arun J. ;

Sterling, Richard K. ;

Stravitz, R. Todd ;

Luketic, Velimir ;

Siddiqui, Mohammad S. ;

Puri, Puneet ;

Fuchs, Michael ;

Lennon, Micheal J. ;

Kraft, Kenneth A. ;

Gilles, HoChong ;

White, Melanie B. ;

Noble, Nicole A. ;

Bajaj, Jasmohan S. .

METABOLIC BRAIN DISEASE, 2014, 29 (04) :1017-1025

[4]

Alireza M, 2016, HEPATOLOGY, V64, p1017A

[5] Bile Acids and Nonalcoholic Fatty Liver Disease: Molecular Insights and Therapeutic Perspectives [J].

Arab, Juan P. ;

Karpen, Saul J. ;

Dawson, Paul A. ;

Arrese, Marco ;

Trauner, Michael .

HEPATOLOGY, 2017, 65 (01) :350-362

[6] Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study [J].

Armstrong, Matthew James ;

Gaunt, Piers ;

Aithal, Guruprasad P. ;

Barton, Darren ;

Hull, Diana ;

Parker, Richard ;

Hazlehurst, Jonathan M. ;

Guo, Kathy ;

Abouda, George ;

Aldersley, Mark A. ;

Stocken, Deborah ;

Gough, Stephen C. ;

Tomlinson, Jeremy W. ;

Brown, Rachel M. ;

Huebscher, Stefan G. ;

Newsome, Philip N. .

LANCET, 2016, 387 (10019) :679-690

[7] Fecal Microbiota Transplant From a Rational Stool Donor Improves Hepatic Encephalopathy: A Randomized Clinical Trial [J].

Bajaj, Jasmohan S. ;

Kassam, Zain ;

Fagan, Andrew ;

Gavis, Edith A. ;

Liu, Eric ;

Cox, I. Jane ;

Kheradman, Raffi ;

Heuman, Douglas ;

Wang, Jessica ;

Gurry, Thomas ;

Williams, Roger ;

Sikaroodi, Masoumeh ;

Fuchs, Michael ;

Alm, Eric ;

John, Binu ;

Thacker, Leroy R. ;

Riva, Antonio ;

Smith, Mark ;

Taylor-Robinson, Simon D. ;

Gillevet, Patrick M. .

HEPATOLOGY, 2017, 66 (06) :1727-1738

[8]

Bajaj JS, 2016, HEPATOLOGY, V64, p1027A

[9] Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy [J].

Bajaj, Jasmohan S. ;

Betrapally, Naga S. ;

Hylemon, Phillip B. ;

Heuman, Douglas M. ;

Daita, Kalyani ;

White, Melanie B. ;

Unser, Ariel ;

Thacker, Leroy R. ;

Sanyal, Arun J. ;

Kang, Dae Joong ;

Sikaroodi, Masoumeh ;

Gillevet, Patrick M. .

HEPATOLOGY, 2015, 62 (04) :1260-1271

[10] Decompensated cirrhosis and microbiome interpretation [J].

Bajaj, Jasmohan S. ;

Betrapally, Naga S. ;

Gillevet, Patrick M. .

NATURE, 2015, 525 (7569) :E1-E2

← 1 2 3 4 5 6 7 8 9 10 →